Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2020-04-29 | Mr. Hannon, 48, currently serves as Chief Executive Officer and as a Director of Mainstay Medical International plc... The Board believes that Mr. Hannon’s experience leading medical device companies will bring valuable industry experience to the Board. ... The following table provides information regarding the 2019 compensation of non-employee directors. ... Jason M. Hannon 35,385 fees earned in cash, no stock awards, total 35,385. |
| 2021-04-29 | Jason M. Hannon Mr. Hannon, 49, was appointed to the Board in June 2020. The Board has resolved that, as of the Annual Meeting, Mr. Hannon will be appointed Chair of the Compliance & Ethics Committee. The following table provides information regarding the 2020 compensation of non-employee directors. Jason M. Hannon Fees Earned or Paid in Cash: 21,923 Restricted Stock Unit Awards: 4,588 Grant Date Fair Value of Restricted Stock Awards: 175,032 Option Awards: 24,701 Grant Date Fair Value of Option Awards: 300,000 Total: 496,955 |
| 2022-04-27 | Mr. Hannon, 50, was appointed to the Board in June 2020. He serves on the Audit and Finance Committee and is Chair of the Compliance and Ethics Committee. He received total compensation of $247,797 in 2021. |
| 2023-04-27 | Jason M. Hannon Independent Director Age 51 Audit & Finance Committee member Compliance & Ethics Committee Chair 2022 compensation: $255,022 |
| 2024-04-29 | Mr. Hannon has served on the Board since June 2020. He is President and CEO of Mainstay Medical International plc. The Board believes that Mr. Hannon’s experience leading medical device companies brings valuable industry experience to the Board. In 2023, Mr. Hannon received $76,250 in cash fees and stock awards valued at $299,999. |
Data sourced from SEC filings. Last updated: 2026-02-03